Back
INmune Bio Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
61
INMB
INmune Bio
Last Price:
9.48
Seasonality Move:
18.37%
Sell
46
SRPT
Sarepta Therapeutics
Last Price:
129.88
Seasonality Move:
5.25%
Buy
61
INmune Bio (INMB)
is a Buy
Is INmune Bio a Buy, Sell or Hold?
- The current INmune Bio [INMB] share price is $9.46. The Score for INMB is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- INMB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $129.86. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $9.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INMB is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $129.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
INMB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 39.07 | Sell |
| Chaikin Money Flow: | -775 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.02 - 11.42) | Sell |
| Bollinger Bands (100): | (10.25 - 12.51) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.13 | Sell |
| Relative Strength Index (14 RSI): | 54.19 | Buy |
| Chaikin Money Flow: | 5641284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.06 - 134.4) | Buy |
| Bollinger Bands (100): | (119.51 - 131.51) | Buy |
INMB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.03 | Sell |
| 20-day SMA: | 10.52 | Sell |
| 50-day SMA: | 10.64 | Sell |
| 200-day SMA: | 9.86 | Sell |
| 8-day EMA: | 9.96 | Sell |
| 20-day EMA: | 10.34 | Sell |
| 50-day EMA: | 10.68 | Sell |
| 200-day EMA: | 10.22 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124 | Buy |
| 20-day SMA: | 129.27 | Buy |
| 50-day SMA: | 126.63 | Buy |
| 200-day SMA: | 114.36 | Buy |
| 8-day EMA: | 124.84 | Buy |
| 20-day EMA: | 126.64 | Buy |
| 50-day EMA: | 126.19 | Buy |
| 200-day EMA: | 118.79 | Buy |
INmune Bio Earnings Growth & INMB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.96 per share, and an increase next year of $0.11 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.
INmune Bio Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||